• Contact Us
Friday, May 27, 2022
Health Business
Advertisement
  • Home
  • News
    Ebola vaccine approved by FDA

    Covid: Fourth-dose jab trial shows good boost

    Microbiology diagnostics: Removing the Kenyan antimicrobial resistance blindfold

    Microbiology diagnostics: Removing the Kenyan antimicrobial resistance blindfold

    Food apps and online gaming driving obesity – WHO

    Food apps and online gaming driving obesity – WHO

    Hepatitis detected in nearly 300 children worldwide

    Hepatitis detected in nearly 300 children worldwide

  • Events
  • Private
    • KHF
    • Providers
  • Government
    • Medical Research
    • Politics & Policy
    • Regulation, Enforcement & Compliance
  • Finance
  • Tech
  • Epaper
  • Videos
  • Home
  • News
    Ebola vaccine approved by FDA

    Covid: Fourth-dose jab trial shows good boost

    Microbiology diagnostics: Removing the Kenyan antimicrobial resistance blindfold

    Microbiology diagnostics: Removing the Kenyan antimicrobial resistance blindfold

    Food apps and online gaming driving obesity – WHO

    Food apps and online gaming driving obesity – WHO

    Hepatitis detected in nearly 300 children worldwide

    Hepatitis detected in nearly 300 children worldwide

  • Events
  • Private
    • KHF
    • Providers
  • Government
    • Medical Research
    • Politics & Policy
    • Regulation, Enforcement & Compliance
  • Finance
  • Tech
  • Epaper
  • Videos
No Result
View All Result
Health Business
No Result
View All Result

Covid-resistant people inspire new vaccine tactic

by Health Business
November 11, 2021
in News
0
Ebola vaccine approved by FDA
Share This:

Understanding how some people naturally resist Covid infection, despite clearly being exposed to the virus, could lead to better vaccines, say researchers.

A team at University College London said some people had a degree of Covid-immunity before the pandemic started.

This likely came from the body learning how to fight viruses that are related to the one which has swept the world.

Upgrading vaccines to copy this protection, could make the jabs even more effective, the team said.

The scientists were closely monitoring hospital staff during the first wave of the pandemic – including by taking regular blood samples.

Despite being in a high-risk environment, not everyone in the study came down with Covid. The results, published in the journal Nature, showed some people just managed to avoid the virus.

But around one-in-10 had signs of being exposed, but never had symptoms, never tested positive and never developed Covid-fighting antibodies in their blood.

Part of their immune system was able to get on top of the virus before it managed to take hold – what’s known as an “abortive infection”.

Blood samples showed these people already had (as in before the pandemic) protective T-cells, which recognise and kill cells infected with Covid.

Dr Leo Swadling, one of the researchers, said their immune systems were already “poised” to fight the new disease.

These T-cells were able to spot a different part of the virus than the bit most of the current vaccines train the immune system to find.

Vaccines are largely aimed at the spike protein, which covers the outer surface of the Covid virus. However, these rare T-cells were able to look inside the virus and find the proteins that are necessary for it to replicate.

“The healthcare workers that were able to control the virus before it was detectable were more likely to have these T-cells that recognise the internal machinery before the start of the pandemic,” Dr Swadling added.

These internal proteins are very similar in all related species of coronavirus, including the ones that are widespread and cause common cold symptoms.

It means targeting these proteins with a vaccine could give some protection against all coronaviruses and new Covid variants.

The team said the current vaccines were doing an excellent job of preventing people from becoming severely ill, but were not as good at stopping them catching Covid.

Prof Mala Maini told me: “I think we could all see that they could do better.

“What we’re hoping, by including these T-cells, is that they might be able to protect against infection as well as disease, and we hope they would be better at recognising new variants that arise.”

While nearly everyone will have caught these common cold coronaviruses, not everyone will have developed the right kind of protective T-cells. It may be that healthcare workers are more regularly exposed to the viruses through their work and that is why some of them had protection.

Dr Alexander Edwards, from the University of Reading, said: “Insights from this study could be critical in the design of a different type of vaccine.

“Hopefully this study will lead to further advances in vaccine development, as we need all the types of vaccine we can get.” -BBC

Share This:
Previous Post

Black women four times more likely to die in childbirth

Next Post

Ending malaria in Africa needs to focus on poverty

Related Posts

Ebola vaccine approved by FDA
News

Covid: Fourth-dose jab trial shows good boost

May 12, 2022
Microbiology diagnostics: Removing the Kenyan antimicrobial resistance blindfold
News

Microbiology diagnostics: Removing the Kenyan antimicrobial resistance blindfold

May 12, 2022
Food apps and online gaming driving obesity – WHO
News

Food apps and online gaming driving obesity – WHO

May 5, 2022
Next Post
Death toll from Rift Valley Fever in Wajir rises to five

Ending malaria in Africa needs to focus on poverty

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

No Result
View All Result

Follow Us

Most Read

  • Microbiology diagnostics: Removing the Kenyan antimicrobial resistance blindfold

    Microbiology diagnostics: Removing the Kenyan antimicrobial resistance blindfold

    0 shares
    Share 0 Tweet 0
  • Understanding of low back pain with recent evidence

    0 shares
    Share 0 Tweet 0
  • Menopause: what are the symptoms and why does it happen?

    0 shares
    Share 0 Tweet 0
Health Business

Health Business contains need-to-know features, news and case studies that explain the administrative and commercial issues affecting healthcare and hospital management. Health Business supports several high profile exhibitions - coverage of which is always timed for maximum impact. Regular topics include ICT, Finance/Funding, Facilities Management, Security, Health & Safety. Contributors range from government ministers through to top-level health administrators and association chairs.

Top Stories

Ebola vaccine approved by FDA

Covid: Fourth-dose jab trial shows good boost

May 12, 2022
Microbiology diagnostics: Removing the Kenyan antimicrobial resistance blindfold

Microbiology diagnostics: Removing the Kenyan antimicrobial resistance blindfold

May 12, 2022
Food apps and online gaming driving obesity – WHO

Food apps and online gaming driving obesity – WHO

May 5, 2022

Interests

  • Events
  • Finance
  • Government
  • Magazines
  • Medical Research
  • News
  • Politics & Policy
  • Providers
  • Public Health
  • Regulation, Enforcement & Compliance
  • Technology
  • Videos

Follow Us

  • Contact Us

© 2019 | Site by Mark & Ryse.

No Result
View All Result
  • Home
  • News
  • Events
  • Private
    • KHF
    • Providers
  • Government
    • Medical Research
    • Politics & Policy
    • Regulation, Enforcement & Compliance
  • Finance
  • Tech
  • Epaper
  • Videos

© 2019 | Site by Mark & Ryse.